Enantioselective Synthesis of the Novel Chiral Sulfoxide Derivative as a Glycogen Synthase Kinase 3β Inhibitor.

A gram scale access to the novel GSK-3β inhibitor (II) is presented using Kagan′s enantioselective oxidation procedure.